NCT03425279 CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma Status COMPLETED Phase PHASE1/PHASE2
NCT03307616 Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02923778 Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02584309 Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Status COMPLETED Phase PHASE2
NCT02565758 ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1